Hashtag Health

How does a Forbes' 30 under 30 boy genius get dubbed the most hated man in America? How about hiking up the price of a life-saving drug by 5000 percent. Is Shkreli just a bad egg, or is he one manifestation of Big Pharma's underlying dynamics when dealing with life-saving therapies? To help answer this question, we interviewed Neil Johnson, the Vice President of Cancer Care at LHSC. In addition to his current leadership role at LHSC, Neil has decades of experience working in oncology and pharmacare due to his background as a palliative care pharmacist.